Having just completed her Ph.D. studies at York University, Esther hails from the world of structural mass spectrometry and hydrogen-deuterium exchange. Her new focus will center on biophysical characterization of novel Huntingtin interactors in the lab of Dr. Rachel Harding.

Manisha is a PhD student under the co-supervision of C. Arrowsmith and R. Harding. Her research focuses on studying Huntingtin-RNA interactions in relevant cell models of Huntington’s disease, employing approaches from molecular, cell and structural biology.

Rebeka Fanti joined SGC Toronto in January 2023 as a PhD student in the Molecular Genetics Department at the University of Toronto. She is exploring the potential application of macrocyclic peptides as tools to investigate the role of the Huntingtin protein in the cell.

Samira is a PhD student at the University of Toronto, co-supervised by Drs. R. Harding and A. Edwards. She completed a BSc in Genetics and MSc in Nanobiotechnology at the University of Tehran. Her current research focuses on a genetic neurodegenerative disorder.

Ailin joined the Harding Lab in September 2024 as a PhD student in the Pharmacology department at the University of Toronto. She completed her BSc in Biology at York University.

Rocher is an MSc student in the Pharmacology & Toxicology Department at the University of Toronto. She graduated with a BSc in Honours Pharmacology from McGill University where she performed biochemical research on Alzheimer’s Disease. Her new focus will be on the biophysics and structural analysis of proteins involved in Huntington’s Disease.

Renu graduated with an MS in Chemical Engineering from Michigan Technological University. Currently, she is working on characterizing protein-protein interactions and detection of protein complexes as a means of understanding disease pathways.

Elisa graduated from Fleming College with an advanced diploma in Biotechnology. She has over ten years of experience producing recombinant proteins for various projects within the SGC.

Caroline is a second-year undergrad specializing in Biological Chemistry at the University of Toronto Mississauga. Her current research focuses on assay development to study protein-ligand interactions.

Kieran joined the Harding lab in his final undergraduate year to research the cancer-linked protein MAGEA3. After his thesis, he continued studying MAGEA3, focusing on solving ligand bound co-crystal structures of MAGEA3 and compounds derived from the SGC’s AS-MS hit identification platform.

Swati graduated with a PhD from the Indian Institute of Science, specializing in biomolecular NMR and biophysics. She then went on to a postdoctoral fellowship at Vanderbilt University to gain expertise in cryo-EM. After a short stint at IIT Delhi setting up and running a national Cryo-EM facility, Swati has joined the Harding lab with a fellowship awarded by the Hereditary Disease Foundation to study novel therapeutic protein targets for Huntington's disease. 

Meaghan joined the Harding Lab as an MSc student in the Department of Pharmaceutical Sciences at the University of Toronto. She graduated with an HBSc in Fundamental Genetics and its Applications at the University of Toronto.